Clinical trial NCT04918082: Assessment of Quality of Life and Treatment Times for Patients With Invasive Type Breast Cancer in Martinique
Official title: Assessment of Quality of Life and Treatment Times for Patients With Invasive Type Breast Cancer in Martinique
Study type: OBSERVATIONAL
Overall status: ACTIVE_NOT_RECRUITING
Conditions: Breast Neoplasms
Quality of Life
Survivorship
Keywords: Breast cancer
Quality of life
Survivorship
Survival
French West Indies
Lead sponsor: University Hospital Center of Martinique
Sponsor class: OTHER
First posted: 2021-06-08
Enrollment: 133
Sex: FEMALE
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: PROBABILITY_SAMPLE
Study population: Patients with breast cancer followed at the Martinique University Hospital

Brief summary: Cancer and its treatments can be factors that alter the quality of life of patients. The induced alteration of the quality of life can influence compliance and impact survival. Considering the after-effects of the treatment, carrying out such a survey will provide for the first time precise information on the main determinants of the quality of life as well as on the care pathway of patients with invasive breast cancer in the Martinique region.

Detailed description: Breast cancer is the second most common cancer in the West Indies and the leading cancer in women. With 215 new cases in Guadeloupe, 204 in Martinique and 56 in French Guiana each year, it accounts for 37%, 33% and 26% of incident cancer cases in women respectively, but also affects men. Its incidence, lower than in France, is increasing over the period 2008-2014. The diagnostic and therapeutic management of cancer can have an impact on the quality of life of patients, taking into account the adverse effects occurring during and after treatment, both in the short and long term. The European Organisation for Research and Treatment of Cancer (EORTC) has developed a series of questionnaires to assess the quality of life of cancer patients, including a general questionnaire (QLQ-C30) and specific modules for breast cancer (EORTC BREAST (EORTC QLQ-BR23)) with the objective of improving professional practices.

Eligibility criteria: Inclusion Criteria:

* Patient over 18 years of age residing in Martinique with invasive breast cancer diagnosed from 2020 (single tumor at diagnosis)
* Patients who have read the information note and have indicated that they do not wish to participate in the study
* Patient with social security coverage.

Exclusion Criteria:

* Refusal to participate
* Patient with insitu breast cancer
* Patient with a second cancer
* Patient with cancer within 5 years prior to inclusion
* Patient who could not answer quality of life questionnaires
* Patient not fluent in French
* Person under legal protection (safeguard of justice, guardianship, curators , etc.).

Primary outcomes:
measure: Assessment of global disorders in patients with breast cancer
timeFrame: 12 months after diagnosis
measure: Assessment of disorders specific to breast cancer patients Assessment of disorders specific to breast cancer patients
timeFrame: 12 months after diagnosis
measure: Assessment of global disorders in patients with breast cancer
timeFrame: 36 months after diagnosis
measure: Assessment of disorders specific to breast cancer patients
timeFrame: 36 months after diagnosis
Secondary outcomes:
Other outcomes:
Locations:
city: Fort-de-France
country: Martinique
facility: CHU Martinique
Study officials:
affiliation: CHU Martinique
name: Clarisse JOACHIM-CONTARET
role: PRINCIPAL_INVESTIGATOR
References: